中国北西部のユリンで発生した2022年9月の雷雨による喘息の発生: 7年後の (2018年-2024年) 遡及的分析 (2018年-2024年)
Meimei Liu1,2, Wenjing Ye3, Xin Liu1,2
1Department of Allergy, Yulin Hospital, The First Affiliated Hospital of Xi'an Jiaotong University, P.R. China.
The Journal of international medical research
|February 23, 2026
まとめ
雷暴性喘息は中国北西部で深刻な脅威となり,マグワート花粉と嵐に関連した症例が急増しています. 早期警告システムは,被災地域の公衆衛生にとって極めて重要です.
科学分野:
- 環境衛生 環境衛生 環境衛生
- エピデミオロジー エピデミオロジー
- アレルギー学 アレルギー学
背景:
- 雷雨による喘息の発生は,公衆衛生上の懸念が高まっています.
- 疫学的パターンを理解することは,効果的な管理に不可欠です.
研究 の 目的:
- 中国北西部のユリンで (2022年9月) 特定の雷雨による喘息の発生を記録する.
- 2018年から2024年までのアレルギー性呼吸器疾患の流行病学的傾向を分析する.
- 疫病発生に関連する危険因子を特定する.
主な方法:
- リトロスペクティブ・オブザーバショナル・スタディ・デザイン.
- ユリン病院と西安通大学の第1附属病院の患者データを活用した.
- 病院の情報システム,医療記録,花粉モニタリングデータの分析が含まれています.
主要な成果:
- アレルギー性呼吸器疾患の年間発生率は4778例から26,459例 (2018年−2024年) に増加した.
- 緊急訪問は,2022年9月の雷雨期間中に2185人に達した.
- 入院した患者のうち,58%は以前に喘息の診断を受けていなかった,70.9%はアレルギー性鼻炎,59.1%はマグワート花粉に敏感であった.
結論:
- 雷暴性喘息は,中国北西部における重要な公衆衛生問題である.
- マグワート花粉と雷雨のコンディションの収束がアウトブレイクを引き起こします.
- 感受性の高い地域には,統合された早期警告システムが緊急に必要である.
さらに関連する動画
05:56A Traditional Chinese Medicine Characteristic Therapy for Bronchial Asthma: Moxibustion
Published on: May 12, 2023
5.5K
05:19Author Spotlight: An Effective Traditional Chinese Medicinal Treatment for Chronic Obstructive Pulmonary Disease with Abdominal Distension
Published on: September 1, 2023
2.2K
関連する概念動画
01:29Asthma-I: Introduction
3.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.6K
01:30Asthma-IV: Diagnostic and Management
3.2K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.2K
01:20Asthma: Pathogenesis and Management
1.5K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.5K
01:26Asthma-II: Pathophysiology and Classification
4.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.6K
01:24Asthma-III: Symptoms and Complications
3.4K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
3.4K
01:24Antiasthma Drugs: Methylxanthines
1.8K
Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
1.8K